HELP Helus Pharma Inc.

Bought an extra 1,000 shares of $HELP and $CMPS near market lows today. Up to 33,500 shares of CMPS and 22,600 shares of HELP, which is more than I wanted but this dip is dipping.

$HELP predictable pre-catalyst FUD. if you are newer to biotech catalyst trading, mark the ‘feeling’ you have today… and buy the biotechs you like whenever you recognize this same feeling… it’s purposely designed to get you to sell, and it usually occurs predictably in most worthwhile tickers and typically close to data. If you aren’t overly frustrated or fearful at some point, it’s probably not a stock that will pay you well, or it’s still too early in the timeline. Stages of accumulation designed to get various retail personalities to predictably sell- 1) pay you more and more, then 2) flush momentum traders from 1 by boring you to death with a pattern that seems unbreakable, then 3) scare you as much as possible on low volume days when accumulation is almost over and their positions are locked. Buffet said it best, be greedy when others are overly fearful. Not much time left to wait brothers

$HELP NUMBER ONE GOAL FOR TOMORROW’S MEETING IS TO GET OUR NAME OUT THERE TO THE WORLD - PRESENT OUR SHORTER CLINIC TIMES AND THE BEST KINETICS AND COST OVER ANY OTHER PSILOCYBIN TREATMENT COMPANIES!!! IT’S TIME WE ARE HEARD

$HELP If you are negative here go out and fuck off. New management gonna bring it to 30$ at least.

$HELP Insiders keep on buying. You're selling? You're not smart. Company value Above 2.5B. Do the math.

$HELP I was glad they did not provide the Phase 3 results yet. It gives me confidence that the results must be good and that the Webcast is to inform Analysts & Investors of how their products will change the world. IMO.

$HELP $HELP H.C. Wainwright reiterated BUY with a $70 price target on Oct 8. Nearly 487% upside from $11.92. Bullish on HLP003 Phase 3 potential, backed by FDA Breakthrough Therapy designation. Major trial results expected in November.

$HELP Get ready for November Phase 3 that will blow CMPS out of the water and allow patients to stay on their antidepressants while trying a treatment for depression with a different pathway (Deuterated Psilocybin)

$HELP MAHA summit Just started.Psychedelic topic starting at 9.40 am $HELP CEO/ $CMPS CEO/ $DFTX CEO will speak there.

$HELP the dip this week has been due to bond yields. Nothing to do with the stock or the broader psychedelics sector at all. They should pull back Monday with an announcement from the White House on an oil flow again deal they are considering with Iran. Halstead buying a 100k shares at 13.47 tells you all you need to know. MAHA Summit next week and then we are in the data drop window with great odds (60-70 percent) for a 2-4x ($25-$50 a share). Today is the day to load.

$HELP Thought I was done buying but in for 500 more shares - have 20,600 shares total now.

$HELP They certainly established the need for a new adjunctive treatment. People largely don't want to take what is now approved. Not only is there a stigma attached to taking an antipsychotic, these drugs also have serious side effects.

$HELP $CMPS now is the time to buy it might get lower too - but we know what we own. In terms of risk, HELP is literally the same compound (clinically speaking) following the same phase 2 design - BOTH are going to be great. I’d rather people who don’t know what they’re holding sell - bye - go invest in space x or the AI bubble, lmao BULLISH on $HELP and $CMPS bc I know what they mean clinically and the world needs both of them desperately. There are NO other treatments like them PERIOD end of story.

$HELP After the call I'm now expecting a -6 to -12 placebo adjusted MADRS 80 per cent odds. Less than -6 10 per cent odds. More than -12 10 per cent odds. And I think anything over a -8 is going to at least double the stock, probable triple. -12 or more probably 4-8x it. Strong asymmetric risk reward profile. Zero AI input. Just my back of grey folded napkin neocortex today. If they had less than -5 in the bag I really doubt they'd have even bothered with that call.

$HELP Excellent recovery but still need to be over the next major MA magnet for proper comfort. $DFTX Compass especially $CMPS however for those who haven't added these are the spots you want to add if you still have stones for Q4 powder keg of catalysts.

$HELP CEO dropping his own personal cash in this, this deep in the game is incredibly bullish.

$HELP Incredible presentation today by four of Helus Pharma’s outstanding staffers, mapping out the current treatment landscape and the massive commercial and humanitarian potential ahead for our pipeline. The team did a phenomenal job illustrating why Helus is uniquely positioned to disrupt the market. If the upcoming HLP003 Phase 3 data proves to be strong, we aren't just looking at an incremental improvement—we are looking at a true world-changing game changer that could dramatically improve patients' lives globally. As an investor, seeing this level of clarity, talent, and ground-breaking science reinforces my confidence in Helus Pharma’s trajectory. The upside here for both patients and shareholders is immense. Due your own due diligence. IMO.

$HELP bottom is in, as I mentioned yesterday. We have a huge opportunity in the next 3 months as a company and for the whole sector to really make serious money. Good luck to everyone this quarter will make or break a lot of investors. For those who have high conviction I hope you accumulated during these lows

$HELP four executives bought ~$8.4M of stock on the open market in the last month: co-founder/exec chair Eric So $3.6M (Sept 1–8), chief growth officer Paul Glavine $3.5M (Aug 31–Sept 8), CEO Michael Halstead $1.35M (Sept 21, more than doubling his stake), and CFO Greg Cavers $39K (Sept 29). None of it was under 10b5-1 plans. That's the C-suite putting real money in ahead of the Q4 APPROACH Phase 3 topline readout. Interesting signal of management confidence into a binary event. We shall see if it proves to be warranted?

$HELP If Phase 3 data shows efficacy that is merely EQUAL to current therapies, HLP003 should still win commercially because current medications come with debilitating side effects that ruin patient compliance. Just look into those side effects (that are likely under reported) and you will understand. Thanks. Not Medical Advice. IMO.